These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 9463021)
1. [Interrelation of visceral fat and muscle mass in non insulin-dependent diabetes (type II): practical implications]. Brun JF; Bringer J; Raynaud E; Renard E; Orsetti A Diabetes Metab; 1997 Nov; 23 Suppl 4():16-34. PubMed ID: 9463021 [TBL] [Abstract][Full Text] [Related]
2. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights. Vaag A Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979 [TBL] [Abstract][Full Text] [Related]
5. [Abdominal obesity and coronary heart disease. Pathophysiology and clinical significance]. Hauner H Herz; 1995 Feb; 20(1):47-55. PubMed ID: 7713476 [TBL] [Abstract][Full Text] [Related]
6. Insulin resistance in Pima Indians. A combined effect of genetic predisposition and obesity-related skeletal muscle cell hypertrophy. Lillioja S; Bogardus C Acta Med Scand Suppl; 1988; 723():103-19. PubMed ID: 3134799 [TBL] [Abstract][Full Text] [Related]
7. [Non-pharmacological therapy of metabolic syndrome]. Wirth A Herz; 1995 Feb; 20(1):56-69. PubMed ID: 7713478 [TBL] [Abstract][Full Text] [Related]
8. [Insulin resistance and pathogenesis of non-insulin-dependent diabetes mellitus (I)]. Martinka E; Ochodnický M; Mokán M Vnitr Lek; 1996 Jan; 42(1):31-6. PubMed ID: 8629358 [TBL] [Abstract][Full Text] [Related]
9. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes. Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758 [TBL] [Abstract][Full Text] [Related]
10. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism. Vestergaard H Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651 [TBL] [Abstract][Full Text] [Related]
11. Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus. Blaak EE Proc Nutr Soc; 2004 May; 63(2):323-30. PubMed ID: 15294050 [TBL] [Abstract][Full Text] [Related]
12. Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Raz I; Eldor R; Cernea S; Shafrir E Diabetes Metab Res Rev; 2005; 21(1):3-14. PubMed ID: 15386813 [TBL] [Abstract][Full Text] [Related]
13. Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus. Venables MC; Jeukendrup AE Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S18-23. PubMed ID: 19662619 [TBL] [Abstract][Full Text] [Related]
14. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Resmini E; Minuto F; Colao A; Ferone D Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513 [TBL] [Abstract][Full Text] [Related]
15. Hypertension in obese and non-obese non-insulin dependent diabetics a matter of regional adiposity? Van Gaal LF; Nobels FR; Rillaerts EG; Creten WL; De Leeuw IH Diabete Metab; 1988; 14(3):289-93. PubMed ID: 3410153 [TBL] [Abstract][Full Text] [Related]
16. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Black PH Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084 [TBL] [Abstract][Full Text] [Related]
18. Adipotoxicity and the insulin resistance syndrome. Anderwald C; Roden M Pediatr Endocrinol Rev; 2004 Mar; 1(3):310-9. PubMed ID: 16437024 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol]. Robaczyk MG Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484 [TBL] [Abstract][Full Text] [Related]
20. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease. Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]